Back to TRDA
UBS Group AG TRDA Position History
Entrada Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$4M
Q3 2026
Peak value
$4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $487 |
| Q3 2025 | $109K |
| Q4 2025 | $194K |
| Q4 2025 | $2K |
| Q1 2026 | $404K |
| Q2 2026 | $640 |
| Q2 2026 | $300K |
| Q2 2026 | $5K |
| Q3 2026 | $4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4M | 624.2K | — | — |
| Q2 2026 | $5K | 685 | — | — |
| Q2 2026 | $300K | 40.8K | — | — |
| Q2 2026 | $640 | 87 | — | — |
| Q1 2026 | $404K | 32.0K | — | — |
| Q4 2025 | $2K | 205 | — | — |
| Q4 2025 | $194K | 18.8K | — | — |
| Q3 2025 | $109K | 18.8K | — | — |
| Q3 2025 | $487 | 84 | — | — |
Other funds holding TRDA
$18.8M
$18.1M
$15.1M
$14.3M
$12.8M